Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis

(2019) Wallace J Brownlee et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

(2019) Till Sprenger et al.   Multiple Sclerosis Journal

Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography

(2019) Marco Pisa et al.   Multiple Sclerosis Journal

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

(2019) Simon Faissner et al.   NATURE REVIEWS DRUG DISCOVERY

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

(2019) Ester Cantó et al.   JAMA Neurology

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study

(2019) Dejan Jakimovski et al.   Annals of Clinical and Translational Neurology

A decade of test-retest reliability of functional connectivity: A systematic review and meta-analysis

(2019) Stephanie Noble et al.   NEUROIMAGE

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairments

(2018) Michael Gurevich et al.   CNS Neuroscience & Therapeutics

Clinical usefulness of prognostic biomarkers in optic neuritis

(2018) A. Tejeda-Velarde et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study

(2018) R. Zivadinov et al.   EUROPEAN JOURNAL OF NEUROLOGY

Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case–control MRI study

(2018) Lorena Lorefice et al.   JOURNAL OF NEUROLOGY

Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’

(2018) Asaff Harel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study

(2018) Alexander Klistorner et al.   NeuroImage-Clinical

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

(2018) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration

(2018) Maria Marcella Laganá et al.   CURRENT NEUROVASCULAR RESEARCH

Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome

(2018) Atay Vural et al.   Multiple Sclerosis Journal

Treatment of multiple sclerosis — success from bench to bedside

(2018) Mar Tintore et al.   Nature Reviews Neurology

Coexistence of Multiple Sclerosis and Alzheimer's disease: A review

(2018) Pauline Luczynski et al.   Multiple Sclerosis and Related Disorders

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome—Sign of Inflammation

(2018) Marc Pawlitzki et al.   Frontiers in Neurology

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis

(2018) Tanuja Chitnis et al.   Annals of Clinical and Translational Neurology

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis

(2017) I. Håkansson et al.   EUROPEAN JOURNAL OF NEUROLOGY

Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis

(2017) Guanmei Cao et al.   EUROPEAN RADIOLOGY

Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?

(2017) Aude Metzger et al.   EUROPEAN RADIOLOGY

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

(2017) Aylin Yilmaz et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis

(2017) Emilie Doche et al.   JOURNAL OF NEURORADIOLOGY

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

(2017) Axel Petzold et al.   LANCET NEUROLOGY

Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T

(2017) Samantha By et al.   MAGNETIC RESONANCE IN MEDICINE

Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain 23Na-MRI and fast 1H-MRSI study

(2017) Maxime Donadieu et al.   Multiple Sclerosis Journal

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

(2017) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Fluid biomarker and electrophysiological outcome measures for progressive MS trials

(2017) Christian Barro et al.   Multiple Sclerosis Journal

Molecular and Metabolic Imaging in Multiple Sclerosis

(2017) Marcello Moccia et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Brain Atrophy in Multiple Sclerosis

(2017) Jaume Sastre-Garriga et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS

(2017) Marco Pisa et al.   NEUROLOGY

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

From neurofilament research to multiple sclerosis clinical practice

(2017) Benedetta Bodini et al.   NEUROLOGY

Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study

(2017) Yaou Liu et al.   RADIOLOGY

Aberrant Network Activity in Schizophrenia

(2017) Mark J. Hunt et al.   TRENDS IN NEUROSCIENCES

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain 23Na-MRI and fast 1H-MRSI study

(2017) Maxime Donadieu et al.   Multiple Sclerosis Journal

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

(2017) Anna M Pietroboni et al.   Multiple Sclerosis Journal

Fluid biomarker and electrophysiological outcome measures for progressive MS trials

(2017) Christian Barro et al.   Multiple Sclerosis Journal

Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N -acetylaspartate

(2017) Emily Turner Wood et al.   NeuroImage-Clinical

Exploration of machine learning techniques in predicting multiple sclerosis disease course

(2017) Yijun Zhao et al.   PLoS One

Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis

(2016) R. Zivadinov et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging

(2016) D. Ontaneda et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study

(2016) Maria Petracca et al.   BRAIN

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis

(2016) J. Mellergård et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study

(2016) Ivan de Kouchkovsky et al.   JOURNAL OF NEUROLOGY

Neurodegeneration in multiple sclerosis and neuromyelitis optica

(2016) Izumi Kawachi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis

(2016) Giacomo Lazzarino et al.   MOLECULAR NEUROBIOLOGY

Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients

(2016) Seyed-Parsa Hojjat et al.   Multiple Sclerosis Journal

Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study

(2016) Axel Petzold et al.   Multiple Sclerosis Journal

Brain atrophy measurements should be used to guide therapy monitoring in MS – YES

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

(2016) Frederik Barkhof   Multiple Sclerosis Journal

Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis

(2016) Gourab Datta et al.   Multiple Sclerosis Journal

Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis

(2016) Vincent Planche et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies

(2016) Lon R. White et al.   NEUROLOGY

Increased total sodium concentration in gray matter better explains cognition than atrophy in MS

(2016) Adil Maarouf et al.   NEUROLOGY

Brain MRI atrophy quantification in MS

(2016) Maria A. Rocca et al.   NEUROLOGY

Neurofilament light chain level is a weak risk factor for the development of MS

(2016) Georgina Arrambide et al.   NEUROLOGY

Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes—A 2-year MR Imaging Study

(2016) Maria A. Rocca et al.   RADIOLOGY

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients

(2016) Seyed-Parsa Hojjat et al.   Multiple Sclerosis Journal

Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study

(2016) Axel Petzold et al.   Multiple Sclerosis Journal

Brain atrophy measurements should be used to guide therapy monitoring in MS – YES

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

(2016) Frederik Barkhof   Multiple Sclerosis Journal

Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis

(2016) Gourab Datta et al.   Multiple Sclerosis Journal

Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis

(2016) Vincent Planche et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis

(2016) Pierre Branger et al.   PLoS One

The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study

(2015) Léorah Freeman et al.   ANNALS OF NEUROLOGY

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis

(2015) Khaled Abdel-Aziz et al.   BRAIN

Retinal axonal loss in very early stages of multiple sclerosis

(2015) A.-H. Maghzi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cerebral Hypoperfusion: A New Pathophysiologic Concept in Multiple Sclerosis?

(2015) Miguel D'haeseleer et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up

(2015) A. Petzold   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The natural history of brain volume loss among patients with multiple sclerosis: A systematic literature review and meta-analysis

(2015) Timothy Vollmer et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

(2015) EL MacMillan et al.   Multiple Sclerosis Journal

A comparison study of cognitive deficits in radiologically and clinically isolated syndromes

(2015) Andrés Labiano-Fontcuberta et al.   Multiple Sclerosis Journal

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

(2015) Àlex Rovira et al.   Nature Reviews Neurology

Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

(2015) Dalia L. Rotstein et al.   JAMA Neurology

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

(2015) EL MacMillan et al.   Multiple Sclerosis Journal

A comparison study of cognitive deficits in radiologically and clinically isolated syndromes

(2015) Andrés Labiano-Fontcuberta et al.   Multiple Sclerosis Journal

The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis

(2015) Georgios Tsivgoulis et al.   Therapeutic Advances in Neurological Disorders

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

(2015) Georgios Tsivgoulis et al.   PLoS One

In vivo evidence of glutamate toxicity in multiple sclerosis

(2014) Christina J. Azevedo et al.   ANNALS OF NEUROLOGY

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

(2014) Regina Schlaeger et al.   ANNALS OF NEUROLOGY

Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study

(2014) Céline Louapre et al.   HUMAN BRAIN MAPPING

PET imaging in multiple sclerosis

(2014) Daniele de Paula Faria et al.   Journal of Neuroimmune Pharmacology

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195

(2014) E. Rissanen et al.   JOURNAL OF NUCLEAR MEDICINE

Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome

(2014) Roberto Cappellani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

(2014) Jeremy Chataway et al.   LANCET

Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging

(2014) Olga Ciccarelli et al.   LANCET NEUROLOGY

Altered Inter-Subregion Connectivity of the Default Mode Network in Relapsing Remitting Multiple Sclerosis: A Functional and Structural Connectivity Study

(2014) Fuqing Zhou et al.   PLoS One

Glucose uptake of the spinal cord in patients with multiple sclerosis detected by 18F-fluorodeoxyglucose PET/CT after walking

(2014) J H Kindred et al.   SPINAL CORD

Impaired Cerebrovascular Reactivity in Multiple Sclerosis

(2014) Olga Marshall et al.   JAMA Neurology

Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

(2014) Jae Young Lee et al.   Acta Neuropathologica Communications

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

(2013) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

(2013) Tarunya Arun et al.   BRAIN

Sodium accumulation is associated with disability and a progressive course in multiple sclerosis

(2013) David Paling et al.   BRAIN

Multiple sclerosis is primarily a neurodegenerative disease

(2013) Abhijit Chaudhuri   JOURNAL OF NEURAL TRANSMISSION

Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis

(2013) L. Debernard et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Topography of brain sodium accumulation in progressive multiple sclerosis

(2013) Adil Maarouf et al.   MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE

Cerebral white matter blood flow and energy metabolism in multiple sclerosis

(2013) Christel Steen et al.   Multiple Sclerosis Journal

The link between resting-state functional connectivity and cognition in MS patients

(2013) Álvaro J Cruz-Gómez et al.   Multiple Sclerosis Journal

The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects

(2013) A. Minagar et al.   NEUROLOGY

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

(2013) M. L. Stromillo et al.   NEUROLOGY

Gray matter damage predicts the accumulation of disability 13 years later in MS

(2013) M. Filippi et al.   NEUROLOGY

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1

(2013) M. D'haeseleer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A hitchhiker's guide to diffusion tensor imaging

(2013) José M. Soares et al.   Frontiers in Neuroscience

Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique

(2012) R.I. Aviv et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

White-Matter Astrocytes, Axonal Energy Metabolism, and Axonal Degeneration in Multiple Sclerosis

(2012) Melissa Cambron et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome

(2012) Efrosini Z. Papadaki et al.   MAGNETIC RESONANCE IN MEDICINE

Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis

(2012) Anthony Faivre et al.   Multiple Sclerosis Journal

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

(2012) M. Politis et al.   NEUROLOGY

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

(2012) I. I. Kirov et al.   NEUROLOGY

Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional23Na MR Imaging Study

(2012) Wafaa Zaaraoui et al.   RADIOLOGY

Multiple sclerosis and glutamate excitotoxicity

(2012) Milos Kostic et al.   REVIEWS IN THE NEUROSCIENCES

Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations

(2011) Natalia M. Moll et al.   ANNALS OF NEUROLOGY

Development of chemical exchange saturation transfer at 7T

(2011) Adrienne N. Dula et al.   MAGNETIC RESONANCE IN MEDICINE

Acidosis, Acid-Sensing Ion Channels, and Neuronal Cell Death

(2011) Yi-Zhi Wang et al.   MOLECULAR NEUROBIOLOGY

Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study

(2011) C Forn et al.   Multiple Sclerosis Journal

Distributed changes in default-mode resting-state connectivity in multiple sclerosis

(2011) Simona Bonavita et al.   Multiple Sclerosis Journal

Multi-task functional MRI in multiple sclerosis patients without clinical disability

(2011) René A. Colorado et al.   NEUROIMAGE

Age and disability accumulation in multiple sclerosis

(2011) A. Scalfari et al.   NEUROLOGY

Role of Astrocytes in Neurovascular Coupling

(2011) Gabor C. Petzold et al.   NEURON

Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis

(2011) D. J. Hawellek et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evidence for a two-stage disability progression in multiple sclerosis

(2010) E. Leray et al.   BRAIN

Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla

(2010) M. Inglese et al.   BRAIN

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Microglia in neurodegenerative disease

(2010) V. Hugh Perry et al.   Nature Reviews Neurology

Spinal cord repair in MS: Does mitochondrial metabolism play a role?

(2010) O. Ciccarelli et al.   NEUROLOGY

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter

(2010) Christel Steen et al.   PLoS One

Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla

(2010) Fahmy Aboul-Enein et al.   PLoS One

Astrocytic β2-adrenergic receptors: From physiology to pathology

(2010) Guy Laureys et al.   PROGRESS IN NEUROBIOLOGY

Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease

(2009) Betty S. van der Veen et al.   ANTIOXIDANTS & REDOX SIGNALING

Mitochondrial changes within axons in multiple sclerosis

(2009) D. J. Mahad et al.   BRAIN

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Advances in the molecular imaging of multiple sclerosis

(2009) Paul M Matthews et al.   Expert Review of Clinical Immunology

Enhanced number and activity of mitochondria in multiple sclerosis lesions

(2009) Maarten E Witte et al.   JOURNAL OF PATHOLOGY

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

(2009) Andrew W. Varga et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

(2009) Bruce D Trapp et al.   LANCET NEUROLOGY

Brain activation in multiple sclerosis: a BOLD fMRI study of the effects of fatiguing hand exercise

(2009) AT White et al.   Multiple Sclerosis Journal

The Brain's Default Network

(2008) Randy L. Buckner et al.   Annals of the New York Academy of Sciences

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Regional DTI differences in multiple sclerosis patients

(2008) S ROOSENDAAL et al.   NEUROIMAGE

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

(2008) R. Zivadinov et al.   NEUROLOGY

Review: Mitochondria and disease progression in multiple sclerosis

(2008) D. Mahad et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY